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Development of genomic and proteomic studies coupled with computational sciences could facilitate 
the discovery of various target proteins and potential inhibitor to be developed as drugs. Several 
researches by molecular docking method have been conducted to design disulfide cyclic peptide ligand 
as potential inhibitors for NS2B-NS3 protease (NS2B-NS3 pro) of dengue virus serotype DENV-2 in 
order to inhibit replication of dengue virus. This research studied and evaluated the interaction of 
ligands and the enzyme in the hydrate state using molecular dynamics simulations at two different 
temperatures. Simulations were performed using two disulfide cyclic peptide inhibitors KRK and RKR, 
along with one linear peptide Bz-Nle-K-R-R-H as standard ligand. The result shows that dynamic 
movement of three proposed ligand in hydrated state affects ligand interactions. RKR ligand has the 
best affinity with the enzyme than KRK and standard ligand. This is shown by the ligand interaction 
with enzyme active site which remains stable during the simulation. At the end of simulation 300 K, 
RKR formed a hydrogen bond with Asp75 and at the end of simulation 312 K, RKR also maintained 
hydrogen bond with Asp75 
 





The development of genomic study is very helpful in the 
process of designing new drugs. Human genome did not 
turn out to offer a direct source for drug development, but 
the proteins which they encode are the usual targets of 
drugs. Today, the field of drug development might seem 
more fertile than ever before, with vast amounts of 
information from genomic and proteomic studies 
facilitating the finding of new targets of drug design 
(Alonso et al., 2006). 
Dengue virus belongs to genus Flavivirus (family 
Flaviviridae), which has four antigenically distinct dengue 
virus serotypes; DENV-1, DENV-2, DENV-3 and DENV-4 
(Lescar et al., 2008). Currently, there is no available 
treatment for a flavivirus infection. No vaccines against 
DENV effective to cure the dengue disease have reached  
the market yet, despite several decades of intensive 
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protect simultaneously against all four antigenically 
distinct serotypes. There is need therefore for antiviral 
compounds that are able to halt flaviviral infections and 
critical in light of the significant worldwide mortality and 
morbidity because of flavivirus infection (Geiss et al., 
2009). 
Dengue virus consists of seven non-structural proteins 
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Yap et 
al., 2007). These nonstructural proteins are responsible 
for replicating the viral genome and altering the host cell 
environment such that replication is efficient and that the 
host innate immune response does not interfere with 
replication (Khan et al., 2008). The NS3 viral protease is 
a potential target for antiviral drugs since it is required for 
virus replication (Tomlinson et al., 2009). For 
NS3protease to be active, it must be in a complex with its 
cofactor NS2B. This protease (NS2B/NS3Pro) plays an 
essential role in the cleavage of the viral precursor 
polyprotein and disruption of this function is lethal to viral 
replication (Geiss et al., 2009). The NS3 protease has 
three  catalytic  triad  residues; His51, Asp75 and  Ser135 




(Brinkworth et al., 1999).  
Yin et al. (2005) had developed a potential and 
selective NS2B-NS3 pro inhibitor based on evaluation of 
the linear tetra peptide aldehyde sequence synthesis; Bz-
Nle-Lys-Arg-Arg-H was the best inhibitor and active in 
NS3 protease of dengue virus. Tambunan et al. (2010) 
had conducted molecular docking method and designed 
seven disulfide cyclic peptide ligands which are potential 
to inhibit NS2B-NS3 pro dengue virus and obtained KRK 
as the best ligand. In molecular docking method, enzyme 
was set in a rigid state, while ligand in a flexible condition. 
But actually, biomolecules such as proteins is in a 
dynamic system. Solvent is included in sthe ystem, which 
will trigger dynamic behavior of enzyme-ligand complex. 
Computational methods that could provide flexible state 
of the enzyme and ligand and consider the influence of 
solvent are molecular dynamics simulation method. 
The aim of this research was to study the interaction of 
three potential inhibitors with NS3-NS2B protease of 
dengue virus in a solute condition on different time scale 
and temperatures by molecular dynamics simulation and 




MATERIALS AND METHODS 
 
Ligands design and preparation 
 
Determination of amino acid sequence was based on natural 
substrate NS3-NS2B protease that is recognized by the active site. 
Amino acids that were used are arginine, lysine, glycine, serine, 
alanine, and threonine. This study used peptides with amino acid 
sequence Bz-Nle-CKRRC KRRH as comparison standard. Peptides 
were designed as cyclic peptides, which are joined by disulfide 
bonding at each terminal cysteine and modeled into three-
dimensional structure using ACDlabs. Peptide optimization was 
carried out by choosing wash option, partial charge and energy 
minimization using MMFF94 force field, gas phase solvation and 
RMS gradient 0.001 kcal / Å mol (Manavalan et al., 2010). 
 
 
NS2B-NS3 protease preparation 
 
Three-dimensional structure of DENV-2 NS2B-NS3 protease with 
code2FOM was obtained from PDB and was then loaded into 
Molecular Operating Environment (MOE) 2008.10. Geometry 
optimization and energy minimization process of the three 
dimensional structure of NS2B-NS3 protease was proceeded by 
removing water molecules and chlorine ion. Enzyme structure was 
first repaired and properly protonated using the Protonate3D option 
in MOE (Feher et al., 2009). Hydrogen atoms in the enzyme 
structure were added by choosing partial charge option, with 
hydrogen partial fix and regulation load of enzymes. Energy 
minimization was performed by employing MMFF94x force field, 
gas phase solvation and RMS gradient 0.05 kcal / Å mol 





Molecular docking was performed by choosing MOE-dock option. 





total number of rotation of 2.5 × 106. Triangle matcher method 
generates poses in a systematic manner and more accurate way 
than the alpha triangle method by aligning the ligand triplet of atoms 
with the triplet of alpha spheres in  cavities  of  tight  atomic  
packing (Feher et al., 2009). A London dG scoring function, G was 
used to rank candidate poses. In refinement, repetition was set to 
100, with only one best pose to be retained. 
 
 
Molecular dynamics simulation 
 
Molecular dynamic simulation was performed by executing MOE-
dynamic option. Born solvation was used in MD simulation with 
RMS gradient 0.05. Complex NS2B-NS3 pro with ligand and NS2B-
NS3 pro without ligand were geometry optimized and energy 
minimized. Energy minimization was performed using MMFF94x 
force field, and Nosé-Poincaré-Andersen (NPA) algorithm was 
employed in this simulation along with NVT ensemble. MD 
simulation in MOE 2008.10 has three main processes; initialization, 
main simulation (include with equilibration) and production. 
MD simulation was performed in two different temperatures. At 
300 K simulation, initialization process was performed for 50 ps, 
main simulation for 5 ns and after main simulation had finished, it 
continued with cooling stage for 20 ps until the temperature 
reached 1 K. At 312 K simulation; heating stage for 20 ps was 
needed after initialization process to increase temperature 300 to 
312 K, and remaining parameters were equal to 300 K simulation. 
The result of both temperature, including position, velocity and 





Drug scan analysis was carried out according to Lipinsky's Rule of 
Five: molecular weight of about 500 g / mol, value of log P < 5, H 
donor < 5, and H acceptor < 10.  
 
 
RESULTS AND DISCUSSION 
 
Molecular docking analysis 
 
Docking process was performed using 49-candidate 
ligands, seven comparator ligands and a standard ligand 
against NS3-NS2B protease enzyme. Ligands were 
arranged to interact only with the selected enzyme active 
site residues, His51, Asp75 and Ser135. Placement 
method that was used was the triangle matcher, which 
indicates random movement of ligands to produce 
optimal binding orientation (Cook, et al., 2009). Binding 
free energy values (Gbinding) was quantified by KA 
biological activity constant with the assumption of 
thermodynamic equilibrium conditions for the formation of 
protein-ligand complex [EI] (Kitchen, et al., 2004). The 
relationship between the value of bond energy (Go) with 
KA and [EI] is directly proportional. Gbinding relatively 
small or negative indicates that the ligand conformations 
formed are in the most stable conformation.  
Our data showed that there were two ligand candidates 
who have the relatively small binding free energy (RKR 
and ARR), compared to standard ligand and ligand CRA. 
Ligand RKR Gbinding value was 22.6955 kcal / mol and 
ligand ARR Gbinding value  was 21.3025 kcal / mol,  while  










the standard ligand had Gbinding value of 20.4984 kcal / 
mol and CRA ligand value of 20.6022 kcal / mol. Based 
on the thermodynamic functions described earlier, 
relationship between Gbinding with constant activity of KA 
and [EI] was directly proportional. Ligand RKR and ARR 
could form better enzyme-inhibitor complex conformation 
compared to standard ligand and CRA. Hydrogen 
bonding that occurs in enzyme-ligand complexes were 
also identified and analyzed. 
The CRA and ARR ligands formed more hydrogen 
bonds with target enzyme compared to standard ligand 
and ligand RKR. However, CRA only form hydrogen bond 
with His51 at the active site of enzyme. As for RKR, 
hydrogen bonds with His51 and Asp75 at the active site 
occurred. ARR formed hydrogen bonds with Asp75 and 
Ser135, and the standard ligand also formed hydrogen 
bonds with His51 and Ser135 (Figure 1).  This hydrogen 
bonding contributes to ligand-enzyme affinity due to 
electrostatic interaction between oxygen atoms or 
nitrogen atoms of ligands with hydrogen atoms of amino 
acid residues of the enzyme or vice versa. 
RKR ligands formed hydrogen bonds with the enzyme 
active site residues, His51 and Asp75. From its 
conformation, RKR were fit in the area of enzyme binding 
sites. Therefore, ligand RKR was proposed as a potential 
competitive inhibitor because it can bind to the enzyme 
binding sites and disrupt the activity of the active site of 
the NS3-NS2B protease enzyme. Non-covalent inter-
actions that occur between enzymes and ligands can 
increase ligand-enzyme affinity. Contact residues of the 
enzyme-ligand complex docking results were identified 
and visualized. From our results, ligand RKR and ARR 
interacted with Tyr residues, both Tyr161 and Tyr150 
while CRA did not have this interaction. Phi () electrons 
in aromatic Tyr150 and Tyr161 might interact with 
arginine residues of RKR and ARR  who  has  conjugated 
 bond to form - interaction. 
 
 
Comparison with KRK 
 
Another molecular docking was then performed to 
compare RKR with previously proposed KRK ligand 
(Tambunan et al., 2010). Results show that after been 
superimposed, RKR had a better conformation compared 
to KRK. Figure 2 shows that RKR (red) were located 
closer to the enzyme active site compared to KRK 
(yellow). RKR also formed hydrogen bonds with residues 
His51 and Asp75 in a closer distance compared to KRK. 
Ligand RKR was also better than standard ligand (Figure 
3). RKR has lower binding energy than standard and 
KRK ligand (Table 1). Interaction between ligands and 
enzyme can be seen in Figure 4. 
 
 
Molecular dynamics analysis 
 
Dynamic behavior of enzyme and enzyme-ligand 
complex in hydrated state were observed in initializing 
process for 6 frames, heating stage for 3 frames, cooling 
stage for 5 frames, generated at each 10 ps of MD 
simulation. Main simulation process was at 300 K for 11 
frames, at 312 K for 12 frames, generated at each 500 
ps. At 300 K, total of 22 frames for each ligand was 
obtained, and at 312 K, 26 frames for each ligand were 
obtained includes the heating stage. 
Born solvation that were used in molecular dynamics 
simulation means that the solvent was included during 
the simulation, so that Esol is also calculated in the 
system. The position, velocity and acceleration were 
saved every 0.5 ps. Simulation at 300 K and 101 kPa 
was    performed   to   examine   enzyme-ligand  complex  
















Table 1. RKR, KRK and Standard ligand binding energy. 
 














model in dynamic processes. The stability of enzyme-
ligand complex can be observed from the position of RKR 
(red ball and stick). It can be seen that there were 
changes in enzyme-ligand complex structures at various 
stages of time (0, 25, 50, 75 and 100ps). Conformation of 
the ligand-enzyme was stable during the molecular 
dynamics shown by the position of ligand (0, 25, 50, 75 
and 100 ps), which remained close to the active site and 
also indicated by the interaction between ligand and 
active site residues (Figures 5 to 7). Interaction with 
contact residues that occurred during the simulation was 
different in each time range and movement. Data showed 
that at least 50 ps until 75 ps were needed to optimize 
ligand-enzyme complex, so interaction with 11 amino 
acid residues occurred. This showed the time between 50 
ps and 75 ps was the time when the conformation  of  the 





After initialization process at 300 K, standard ligand could 
still interact with one active site residue of the enzyme; 
Ser135. But at 500 ps until the end of the simulation, the 
standard ligand showed no interaction with the active site 
residues of the enzyme. For KRK, interaction with active 
site residues of the enzyme did not occurred after 4000 
ps of simulation. As for RKR, interactions with enzyme 
active site were still maintained along the simulation. At 
the end of simulation, RKR formed hydogen bonds with 
Asp75 (Figure 8). Throughout the simulation, RKR and 




























standard ligand had no interaction with Asp129 during 
simulation. Asp129 of NS3 protease has an important 
role in stabilizing the base amino acids such as arginine 
or lysine at an inhibitor (Li et al., 2005).  
More  also,   the   heating   stage   at  312 K  influenced 
ligand-enzyme interaction greatly if compared with 
simulation at 300 K. After the heating stage, the standard 
and KRK lost interaction with active site. Standard ligand 
lost interaction with Asp75 and His51, while KRK lost 
interaction   with  Ser135.  But  RKR  could  still  maintain  












Figure 8. RKR-enzyme interaction after molecular dynamics at 300 K. 
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stable hydrogen bonds with Asp75 from the beginning 
until the end of simulation (Figure 9). Ligand interaction at 






Displacement of ligand positions that occurred on ligand 
conformation during the simulation showed that ligands 
moved away from the binding site area. KRK had slightly 
displacement position of conformation from the binding 
site area and could still maintain several interaction with 
the binding site; Asp129, Asn152, Gly133 and Tyr150, 
but KRK could not interact with the active site residues of 
the enzyme. Dynamic movement in the hydrated state of 
enzyme-RKR complex did not influence the position of 
RKR at the binding site area. Structure of the enzyme 
and enzyme-ligand remained stable. Each constituent 
amino acid residues had distinct movement in solvent 
and the presence of inhibitor had different effect, and 
therefore generated different conformation. 
 
 
Drug scan analysis 
 
Log P is the partition coefficient defined as the ratio of the 
concentration of a molecule in octanol and water. Log P 
describes the hydrophobicity of drug molecules. Drug 
molecule should not be hydrophobic or hydrophilic due to 
lining of lipid bilayer. Hydrophobic drug molecules tend to 
have greater toxicity and more widely distributed in the 
body. Only RKR ligand fulfilled the criteria according to 
the Lipinsky rules of good medicine. RKR showed Log P 
















Figure 10. (a) Standard ( Bz-Nle-K-R-R-H) at 300 K; (b) standard ( Bz-Nle-K-R-R-H) at 312K; (c) KRK at 
300K; (d) KRK at 312 K; (e) RKR at 300K; (f) RKR at 312 K. 
Standard ligand (Bz-Nle-K-R-R-H) 
 
 











            (e) 300 K                                                                                                                         (f) 312 K 




the hydrated state at two different temperature conditions 
showed different effect on ligand interaction with NS2B-
NS3 pro dengue virus type 2. Interaction changes 
occurred in residue contacts and hydrogen bonds 
between ligand and amino acids residue of the enzyme. 
Docking results indicate that three ligands could interact 
with enzyme active site residues. MD simulation showed 
that only RKR interacted with the active site of the 
enzyme during simulation. At the end simulation at 300 K, 
RKR formed hydrogen bond with Asp75, while at the end 
simulation at 312 K, RKR maintained hydrogen bond with 
Asp75. RKR conformation was suitable to fit in the 
binding site of enzyme during the simulation. Ligand-
enzyme complex conformation remained stable during 
simulation, as well as the conformation of the enzyme 
without ligand. Based on the analysis of ligand 
interactions and conformational compatibility amongst 
three proposed ligands from this study, RKR showed 
potential to bind the active enzyme and had the best 
affinity to the enzyme. Thus, we proposed RKR as 
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